Chronic Obstructive Pulmonary Disease

• Research Site — London, UK, United Kingdom

• Novartis Investigator Site — Normal, Illinois, United States
• Novartis Investigator Site — Shawnee Mission, Kansas, United States
• Novartis Investigator Site — Lafayette, Louisiana, United States
• Novartis Investigator Site — Charlotte, North Carolina, United States

• Novartis Investigative site — Kasukabe, Japan
• Novartis Investigator Site — Kishiwada, Japan
• Novartis Investigative Site — Kurume, Japan
• Novartis Investigative Site — Obihiro, Japan

• Maastricht UMC — Maastricht, Netherlands

• Novartis Investigator Site — Torrance, California, United States
• Novartis Investigator Site — Lebanon, New Hampshire, United States
• Novartis Investigator Site — Brussels, Belgium
• Novartis Investigator Site — Gembloux, Belgium

• Research Site — Gothenburg, Sweden
• Research Site — Luleå, Sweden
• Research Site — Lund, Sweden

Not specified

• Research Site — Adana, Turkey (Türkiye)
• Research Site — Ankara, Turkey (Türkiye)
• Research Site — Antalya, Turkey (Türkiye)
• Research Site — Aydin, Turkey (Türkiye)

• Oslo University Hospital Ullevaal, Department of Pulmonary Medicine — Oslo, Norway

• University Center for Chronic Diseases Dekkerswald — Groesbeek, Netherlands
• Primary care, general practitioners — Nijmegen, Netherlands